|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Salarius Pharmaceuticals, Inc (SLRX) |
|
|
$0.61 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
2,280,000 |
Market
Cap: |
1.38(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6068 - $0.6068 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s pipeline consists of two compounds: seclidemstat (SP-2577), a small molecular inhibitor and SP-3164, a small molecular protein degrader. SP-2577 is a small-molecule lysine specific demethylase 1 (LSD1) inhibitor with a scaffold. LSD1 is an enzyme that is, in part, responsible for epigenetic regulation of genes that support cancer growth. SP-3164 is a cereblon binding molecular glue. SP-3164 degrades transcription factors IKZF1 and IKZF3, along with other proteins, resulting in both direct anti-cancer activity and immune-modulating properties. SP-3164 has activity in both hematologic and solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
91,753 |
Total Buy Value |
$0 |
$0 |
$0 |
$17,002 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hanish Arnold C |
Director |
|
2019-11-25 |
4 |
B |
$3.59 |
$10,770 |
D/D |
3,000 |
6,000 |
2.39 |
- |
|
Jordan Scott |
Chief Financial OfficerOfficer |
|
2019-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,309 |
|
- |
|
Northrup Jonathan P |
Director |
|
2019-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
344,013 |
|
- |
|
Arthur David J. |
Chief Executive OfficerOfficer |
|
2019-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,371 |
|
- |
|
Lammers Paul |
Director |
|
2019-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,974 |
|
- |
|
Boston Foundation, Inc. |
10% Owner |
|
2019-01-09 |
4 |
S |
$0.37 |
$123,848 |
D/D |
(337,000) |
1,600,000 |
|
- |
|
Boston Foundation, Inc. |
10% Owner |
|
2019-01-08 |
4 |
S |
$0.40 |
$104,306 |
D/D |
(263,000) |
1,937,000 |
|
- |
|
Westphal Christoph H |
10% Owner |
|
2018-10-16 |
4 |
S |
$0.92 |
$2,941,053 |
I/I |
(3,212,861) |
0 |
|
- |
|
Longwood Fund Ii, L.p. |
10% Owner |
|
2018-10-16 |
4 |
S |
$0.92 |
$2,941,053 |
D/D |
(3,212,861) |
0 |
|
- |
|
Westphal Christoph H |
President and CEO |
|
2016-11-08 |
4 |
B |
$7.31 |
$51,170 |
D/D |
7,000 |
3,941,118 |
3.23 |
- |
|
Mccabe John P. |
VP of Finance & Treasurer |
|
2016-11-07 |
4 |
B |
$6.01 |
$9,917 |
D/D |
1,650 |
1,650 |
2.74 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-11-07 |
4 |
B |
$5.70 |
$50,559 |
D/D |
8,870 |
3,934,118 |
3.23 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-23 |
4 |
B |
$11.28 |
$30,456 |
I/I |
2,700 |
3,212,861 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-22 |
4 |
B |
$11.03 |
$31,987 |
I/I |
2,900 |
3,210,161 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-21 |
4 |
B |
$11.07 |
$30,996 |
I/I |
2,800 |
3,207,261 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-20 |
4 |
B |
$11.37 |
$34,110 |
I/I |
3,000 |
3,204,461 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-17 |
4 |
B |
$10.98 |
$32,940 |
I/I |
3,000 |
3,201,461 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-16 |
4 |
B |
$11.10 |
$32,190 |
I/I |
2,900 |
3,198,461 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-15 |
4 |
B |
$11.24 |
$32,596 |
I/I |
2,900 |
3,195,561 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-14 |
4 |
B |
$11.19 |
$33,570 |
I/I |
3,000 |
3,192,661 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-13 |
4 |
B |
$11.90 |
$34,510 |
I/I |
2,900 |
3,189,661 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-10 |
4 |
B |
$11.83 |
$35,490 |
I/I |
3,000 |
3,186,761 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-09 |
4 |
B |
$12.04 |
$36,120 |
I/I |
3,000 |
3,183,761 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-08 |
4 |
B |
$12.24 |
$35,496 |
I/I |
2,900 |
3,180,761 |
2.64 |
- |
|
Westphal Christoph H |
President and CEO |
|
2016-06-07 |
4 |
B |
$12.26 |
$36,780 |
I/I |
3,000 |
3,177,861 |
2.64 |
- |
|
156 Records found
|
|
Page 3 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|